Abstract:
Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
Abstract:
In a method and an apparatus for forming metal oxide on a substrate, a source gas including metal precursor flows along a surface of the substrate to form a metal precursor layer on the substrate. An oxidizing gas including ozone flows along a surface of the metal precursor layer to oxidize the metal precursor layer so that the metal oxide is formed on the substrate. A radio frequency power is applied to the oxidizing gas flowing along the surface of the metal precursor layer to accelerate a reaction between the metal precursor layer and the oxidizing gas. Acceleration of the oxidation reaction may improve electrical characteristics and uniformity of the metal oxide.
Abstract:
A control device which controls a device is disclosed. The control device can be connected to at least one external device, and includes a display unit which generates and displays a frame; and a control unit which controls the display unit to add at least one frame corresponding to each of the at least one external device or to pre-installed applications. The control unit further controls the display unit to display corresponding content in each frame.
Abstract:
The present invention relates to a diagnostic cancer marker using variation of a granulocyte colony stimulating factor (G-CSF) gene and a method for preparing the same, and more specifically, relates to a method for diagnosing cancer and/or assessing the state of cancer progression using an oligonucleotide having the 3′-terminal end of exon 2 region linked to the 5′-terminal end of exon 4 region of a G-CSF gene as a diagnostic cancer marker. According to the present invention, cancer can be quickly and exactly diagnosed using variation in a G-CSF gene expression.
Abstract:
A projectile is provided, including an arrowhead body formed of a predetermined length and coupled to a tip of an arrow shaft, and at least two blades protruding at equal intervals from an outer circumferential surface of the arrowhead body, and shaped to be curved to a predetermined direction to result in a rotation by air during a flight of an arrow, in which one or more ogives for reducing air resistance are formed on outer ends of the blades. Accordingly, the projectile is provided, which can significantly reduce the air resistance during flight compared to the related arrowheads, and since rotation can be induced in itself by the air encountered during the flight, the rotational force and the straightness of the projectile are greatly enhanced, and as a result, it is possible to improve the accuracy of hitting on targets, and increase the destructive power against the target when hitting the target.
Abstract:
A lateral flow atomic layer deposition device according to an exemplary embodiment of the present invention eliminates a gas flow control plate in a conventional lateral flow atomic layer deposition device and controls shapes of a gas input part and a gas output part in a reactor cover to make a gas flow path to a center of a substrate shorter than a gas flow path to an edge of the substrate and thereby increase the amount of gas per unit area flowing to the center of the substrate. Therefore, film thickness in the center of the substrate in the lateral flow reactor increases.
Abstract:
A control device which controls a device is disclosed. The control device can be connected to at least one external device, and includes a display unit which generates and displays a frame; and a control unit which controls the display unit to add at least one frame corresponding to each of the at least one external device or to pre-installed applications. The control unit further controls the display unit to display corresponding content in each frame.
Abstract:
Provided is a detection method of a biochemical material using surface-enhanced Raman scattering in order to detect the existence of a biochemical material in a target subject or its content therein, more particularly a detection method of a biochemical material facilitating multiplex detection with high-sensitivity, high-reproducibility, high-reliability, and high-precision owing to multiple hot spots formed on the nanowire surface of a single crystal body by the bond of multiple nanoparticles which are physically separated from each other.
Abstract:
A deposition apparatus according to an exemplary embodiment of the present invention is a lateral-flow deposition apparatus in which in which a process gas flows between a surface where a substrate is disposed and the opposite surface, substantially in parallel with the substrate. The lateral-flow deposition apparatus includes: a substrate support that moves up/down and rotates the substrate while supporting the substrate; a reactor cover that defines a reaction chamber by contacting the substrate support; and a substrate support lifter and a substrate support rotator that move the substrate support.
Abstract:
The present invention relates to a medicine for treating Avellino corneal dystrophy (ACD), and more particularly, to a pharmaceutical composition for treating Avellino corneal dystrophy containing an antibody against TGF-β as an effective ingredient. The pharmaceutical composition of the present invention has an effect of improving symptoms of a patient with severe Avellino corneal dystrophy due to TGF-β induced by exposure to intense light, such as UV etc.